Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33 | 13 | 15 | 18 | 8 |
| Receivables | 82 | 67 | 27 | 35 | 8 |
| Inventories | 119 | 132 | 159 | 168 | 181 |
| TOTAL | $264 | $244 | $210 | $235 | $220 |
| Non-Current Assets | |||||
| PPE Net | 61 | 36 | 38 | 43 | 30 |
| Intangibles | 193 | 183 | 170 | 164 | 147 |
| TOTAL | $254 | $219 | $208 | $206 | $177 |
| Total Assets | $518 | $463 | $418 | $441 | $396 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 817 | 655 | 549 | 485 | 423 |
| TOTAL | $1,274 | $1,109 | $919 | $544 | $748 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 60 | 330 | 65 |
| TOTAL | $2 | $2 | $63 | $333 | $65 |
| Total Liabilities | $1,276 | $1,111 | $982 | $877 | $813 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,445 | 7,445 | 7,444 | 7,222 | 7,172 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -5,781 | -5,328 | -5,038 | -4,758 | -4,364 |
| Other shareholders' equity | -382 | -444 | -437 | -425 | -460 |
| TOTAL | $-758 | $-648 | $-564 | $-436 | $-417 |
| Total Liabilities And Equity | $518 | $463 | $418 | $441 | $396 |